ahead of Coyden Generic Name: clopidol powder Dosage Form: FOR ANIMAL USE ONLY Coyden 25 Type A Medicated Article FRONT PANEL NADA 034-393 Approved by the FDA Coyden 25% Clopidol Type A Medicated Article ACTIVE DRUG INGREDIENT: Clopidol.................................113.5 gm/lb (25%) INGREDIENTS: Rice Hulls, Mineral Oil, Fatty Acid Glycerides BROILER/REPLACEMENT CHICKENS: As and aid in the prevention of cecal and intestinal cocciodiosis caused by E. Tenella, E. Necatrix, E. acervulina, E. maxima, E. Brunetti, E. mivati. TURKEYS: As an aid in the prevention of leucocytozoonosis caused by Leucocytozoon smithi. SEE DIRECTIONS ON BACK PANEL FOR THE MANUFACTURE OF COMPLETE FEEDS ONLY. Manufactured by: HUVEPHARMA, INC., ST. LOUIS, MO 63116 Huvepharma, Inc. 500 Wespark Drive, Suite 230 Distributed by: Peachtree City, GA 30269 HUVEPHARMA, INC., Peachtree City, GA 30269 For questions, call 1877-426-7765 Coyden is a registered trademark of Huvepharma, Inc. Net Wt. 50 lb (22.68 kg) Bag Back Panel - Mixing Directions and Permitted Claims Restricted Drug (California) Use only as Directed INDICATIONS: BROLER AND REPLACEMENT CHICKENS As an aid in the prevention of coccidiosis in broliers and replacements for caged layers caused by E. tenella, E. necatrix, E. Acervulina, E, maxima, E. brunetti, E mivati. TURKEYS GROWN FOR MEAT PURPOSES ONLY As an aid in the prevention of leucocytozoonosis caused by Leucocytozoon smithi. WARNING: Keep this and all drugs out of the reach of children. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse effects, obtain an MSDS or for assistance, contact Huvepharma at 1-877-426-7765. RESIDUE INFORMATION: CHICKENS: When feeding 0.025% clopidol, reduce dosage to 0.0125% or withdraw medication 5 days before slaughter. Do not feed to chickens over 16 weeks of age. TURKEYS: Withdraw medication 5 days before slaughter. CAUTION: Consult a veterinarian or poultry pathologist if losses exceed 0.5% in a 2-day period. MIXING DIRECTIONS: For Complete Rations - Type C MedIcated Products Coyden 25% (clopidol) should be thoroughly and evenly mixed in the feed in accordance with current good manufacturing practice for medicated feed. Coyden 25% may be used to manufacture a Type C medicated feed in the concentration range of 0.0125% to 0.025% clopidol. To aid in even distribution of Coyden 25% in the finished feed, prepare a mixture of Coyden 25% in a portion of complete feed ingredient before mixing into the finished ration. Blend the mixture with the remainder of the finished feed and mix thoroughly. DIRECTIONS FOR USE: Must be mixed with other ingredients before feeding. Mixing and conveying equipment should be properly grounded. Use 1 pound of Coyden 25% per ton of feed to produce a feed containing 0.0125% clopidol. Use 2 pounds of Coyden 25% per ton of feed to produce a feed containing 0.025% clopidol. FEEDING DIRECTIONS: Feed continuously, as the sole ration, either the 0.0125% or 0.025% Type C medicated feed depending upon management practices, degree of exposure, and amount of feed eaten. STORE IN A COOL PLACE KEEP BAG TIGHTLY CLOSED Coyden 25 (clopidol) Type A Medicated Article Storage and Handling STORE IN A COOL PLACE, KEEP BAG TIGHTLY CLOSED Bag Label Image Bag Label Image Coyden clopidol powder Product Information Product Type OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG Item Code (Source) NDC:23243-9568 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CLOPIDOL (CLOPIDOL) CLOPIDOL 250.2 g in 1 kg Inactive Ingredients Ingredient Name Strength MINERAL OIL RICE BRAN Product Characteristics Color brown ((Light Tan to Brown)) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:23243-9568-5 22.68 kg in 1 BAG Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NADA NADA034393 05/29/2009 Labeler - Huvepharma, Inc. (619153559) Registrant - Huvepharma AD (552691651) Establishment Name Address ID/FEI Operations Huvepharma, Inc. 619153559 manufacture, analysis, pack, label Revised: 03/2010 Huvepharma, Inc. Print this page FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More a reasonably big
extensively utilized Coyden photographs
EmoticonEmoticon